CVS Health Corporation CVS

Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 2, 2026, to holders of record on October 22, 2026.

Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.

WOONSOCKET, RI / ACCESS Newswire / September 30, 2026 / Originally published on Company NewsroomMillions of people across the United States face food insecurity, making it harder to stay healthy, manage chronic conditions and focus on everyday life. During Hunger Action Month, is highlighting the organizations working every day to ensure individuals and families can access the nutritious meals they need.

Alex Milanoski of Newstreet Properties, 1165 North Clark Street in Chicago and Daniel Sobelman of CRE Bridge Capital (LinkedIn, Newstreet Properties, CRE Bridge Capital)A Chicago-based multifamily developer acquired a seven-story office building for $6.8 million last week, with plans to convert it into an 80-unit multifamily complex in the Gold Coast neighborhood, The Real Deal learned. Newstreet, recently rebranded from Initium Development, purchased the property at 1165 North Clark Street, anc

UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.

Brian Shaw and Constantine Malaxos join as enterprise customers expand across financial services, healthcare, and technologySAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Coverbase, AI engineered for third-party risk management (TPRM), today announced that Brian Shaw has joined as GTM Lead and Constantine Malaxos as Head of Alliances. Both bring decades of experience building and selling third-party risk technology to large enterprises. In less than a year since closing its Series A, Coverbas

Sree Chaguturu, MD, President of Health Care Delivery, WOONSOCKET, RI / ACCESS Newswire / September 29, 2026 / Originally published on Company NewsroomKey points * Value-based primary care has stalled in many places not because the model is wrong, but because too many have approached it as a contracting exercise, signing the risk deal and documenting patients' clinical conditions, instead of the harder work of integrating care around the patient. * Scaling it takes connecting the whole system ar

NORTHAMPTON, MA / ACCESS Newswire / September 28, 2026 / Originally published on Company NewsroomWhen students and teachers return to the classroom, having the right supplies can make a meaningful difference. This year, and Aetna teamed up with community organizations and some of our sports partners - The Washington Spirit, Kansas City Current and the Boston Red Sox - to help students and their families start the school year with the resources, confidence, and support they need to thrive.

CVS Health (NYSE:CVS) and ad tech firm Criteo agreed to a US$20.5 million settlement resolving website tracking litigation over user data. The suit alleged CVS Health shared personal and protected health information with third parties through online tracking tools without user consent. The agreement covers claims that Criteo received sensitive CVS website visitor data that was allegedly used for targeted advertising purposes. This US$20.5 million privacy settlement over CVS website tracking...

Why CVS Health Stock Is Back On Traders’ Screens CVS Health (CVS) has jumped back into focus after a 4.8% move on September 25 pushed the share price to $89.13 and back above its 200 day EMA. That single session pulled the stock higher even as the broader daily trend still points lower. This has given short term traders fresh technical signals, while longer term investors are assessing whether this latest bounce changes the story. Set against that sudden spike, CVS Health has had a mixed run,...

Billionaire Mark Cuban says that, in some cases, it might actually be cheaper to pay cash for certain treatments and prescriptions.

Learn how to protect yourself from this growing problem.

CVS customers in Arizona may be owed money from a lawsuit settlement involving the company. Here's what you need to know.

Cuban believes in Medicare for All, but thinks people need to temper their expectations. He thinks a recently introduced bill is most consumers' best shot for now.